Drug makers raise prices in face of healthcare reform

New York Times, November 16, 2009

In the last year, the drug industry has raised the wholesale prices of brand-name prescription drugs by about 9%, according to industry analysts. That will add more than $10 billion to the nation's drug bill, which is on track to exceed $300 billion this year. Drug makers say they have valid business reasons for the price increases, but critics say the industry is trying to establish a higher price base before Congress passes legislation that tries to curb drug spending in coming years.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.